Biomarker-driven protocol model broadens lung cancer trial access for some underrepresented groups

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainAs compared to conventional, stand-alone clinical trials in advanced non-small cell lung cancer (NSCLC), the biomarker-driven Lung Cance

Updated on: January 04,2024

Biomarker-driven protocol model broadens lung cancer trial access for some underrepresented groups

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainAs compared to conventional, stand-alone clinical trials in advanced non-small cell lung cancer (NSCLC), the biomarker-driven Lung Cance

Updated on:January 04,2024

Exploring ways to overcome cisplatin resistance and alleviate pain in cancer treatment

by Korea University College of MedicineThe study reveals that the transcription factor NANOG activates the transient receptor potential vanilloid 1 (TRPV1)—causing neuropathic pain. TRPV1 further stim

Updated on: January 07,2024

Exploring ways to overcome cisplatin resistance and alleviate pain in cancer treatment

by Korea University College of MedicineThe study reveals that the transcription factor NANOG activates the transient receptor potential vanilloid 1 (TRPV1)—causing neuropathic pain. TRPV1 further stim

Updated on:January 07,2024

Scientists discover how excessive red meat consumption increases colorectal cancer risk

byAgency for Science, Technology and Research (A*STAR), SingaporeIdentification of SP2509 and its target Pirin as a regulator of hTERT in colorectal cancer. Credit:Cancer Discovery(2

Updated on: November 10,2024

Scientists discover how excessive red meat consumption increases colorectal cancer risk

byAgency for Science, Technology and Research (A*STAR), SingaporeIdentification of SP2509 and its target Pirin as a regulator of hTERT in colorectal cancer. Credit:Cancer Discovery(2

Updated on:November 10,2024

A non-coding RNA lasso catches proteins in breast cancer cells

by Lisbeth Heilesen,Aarhus UniversityThe authors show that the long non-coding RNA called A-ROD (Activating Regulator Of DKK1 expression) is only functional the moment it is released from chroma

Updated on: May 20,2024

A non-coding RNA lasso catches proteins in breast cancer cells

by Lisbeth Heilesen,Aarhus UniversityThe authors show that the long non-coding RNA called A-ROD (Activating Regulator Of DKK1 expression) is only functional the moment it is released from chroma

Updated on:May 20,2024

Tumor-infiltrating lymphocyte therapy marks a milestone in cancer treatment, researchers say

byH. Lee Moffitt Cancer Center & Research InstituteCancer cell during cell division. Credit: National Institutes of HealthThe recent U.S. Food and Drug Administration approval of lifileucel,

Updated on: August 03,2024

Tumor-infiltrating lymphocyte therapy marks a milestone in cancer treatment, researchers say

byH. Lee Moffitt Cancer Center & Research InstituteCancer cell during cell division. Credit: National Institutes of HealthThe recent U.S. Food and Drug Administration approval of lifileucel,

Updated on:August 03,2024

Are the benefits of new cancer drugs worth the cost?

by Sbarro Health Research Organization (SHRO)The rate of growth in costs (red) vs. outcomes (green) of cancer care, is here expressed as the derivative D[fx0] of both functions (i.e.: the angular coef

Updated on: January 12,2024

Are the benefits of new cancer drugs worth the cost?

by Sbarro Health Research Organization (SHRO)The rate of growth in costs (red) vs. outcomes (green) of cancer care, is here expressed as the derivative D[fx0] of both functions (i.e.: the angular coef

Updated on:January 12,2024

Researchers analyze cancer discrepancies among young Black men in the South

by Vinod Hopson,University of Texas Health Science Center at HoustonRegional Kaposi sarcoma incidence rate trends in non-Hispanic White men aged 20-34. Abbreviation: AAPC, average annual percent

Updated on: January 30,2024

Researchers analyze cancer discrepancies among young Black men in the South

by Vinod Hopson,University of Texas Health Science Center at HoustonRegional Kaposi sarcoma incidence rate trends in non-Hispanic White men aged 20-34. Abbreviation: AAPC, average annual percent

Updated on:January 30,2024

Meningioma molecular profile reliably predicts tumor recurrence

by Baylor College of MedicineCredit: CC0 Public DomainAlthough typically benign, about one-fifth of meningiomas, the most common primary brain tumors, recur despite complete surgical removal. The

Updated on: March 12,2024

Meningioma molecular profile reliably predicts tumor recurrence

by Baylor College of MedicineCredit: CC0 Public DomainAlthough typically benign, about one-fifth of meningiomas, the most common primary brain tumors, recur despite complete surgical removal. The

Updated on:March 12,2024

Minimally invasive, cost-effective method shows promise in treating cancer without harming healthy cells

by Purdue UniversityA Purdue innovation, called PLASMAT, combines three emerging techniques that appear promising in the fight against most types of cancer. Credit: Purdue UniversityPurdue Univer

Updated on: March 12,2024

Minimally invasive, cost-effective method shows promise in treating cancer without harming healthy cells

by Purdue UniversityA Purdue innovation, called PLASMAT, combines three emerging techniques that appear promising in the fight against most types of cancer. Credit: Purdue UniversityPurdue Univer

Updated on:March 12,2024

Using math to better treat cancer

by University of WaterlooGraphical abstract. Credit:Journal of Mathematical Biology(2022). DOI: 10.1007/s00285-022-01819-yResearchers at the University of Waterloo have identified a n

Updated on: January 28,2024

Using math to better treat cancer

by University of WaterlooGraphical abstract. Credit:Journal of Mathematical Biology(2022). DOI: 10.1007/s00285-022-01819-yResearchers at the University of Waterloo have identified a n

Updated on:January 28,2024

New tech addresses manufacturing bottlenecks for a lifesaving blood cancer treatment

byUniversity of South AustraliaSchematic of forces acting on cells in inertial microfluidics. Credit:Cytotherapy(2024). DOI: 10.1016/j.jcyt.2024.05.005Researchers from the University

Updated on: July 30,2024

New tech addresses manufacturing bottlenecks for a lifesaving blood cancer treatment

byUniversity of South AustraliaSchematic of forces acting on cells in inertial microfluidics. Credit:Cytotherapy(2024). DOI: 10.1016/j.jcyt.2024.05.005Researchers from the University

Updated on:July 30,2024

Ovarian cancer detection takes a step forward

byUniversity of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainA new type of technology can capture stray ovarian cancer cells from a simple blood test and successfully predict cancer

Updated on: December 28,2023

Ovarian cancer detection takes a step forward

byUniversity of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainA new type of technology can capture stray ovarian cancer cells from a simple blood test and successfully predict cancer

Updated on:December 28,2023